Semisynthetic aminoglycoside antibiotics. IV. 3',4'-Dideoxyparomomycin and analogues. 1982

C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo

UI MeSH Term Description Entries
D010303 Paromomycin An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES. Aminosidine,Catenulin,Estomycin,Hydroxymycin,Neomycin E,Gabbromycin,Humatin,Paramomycin,Paromomycin I,Paromomycin Phosphate,Paromomycin Sulfate,Paromomycin Sulfate (1:1),Paromomycin Sulfate (2:5),Paromomycin, beta-D-Glucopyranosyl-Isomer,Paromomycin, beta D Glucopyranosyl Isomer,beta-D-Glucopyranosyl-Isomer Paromomycin
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D012270 Ribosomes Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION. Ribosome
D012441 Saccharomyces cerevisiae A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement. Baker's Yeast,Brewer's Yeast,Candida robusta,S. cerevisiae,Saccharomyces capensis,Saccharomyces italicus,Saccharomyces oviformis,Saccharomyces uvarum var. melibiosus,Yeast, Baker's,Yeast, Brewer's,Baker Yeast,S cerevisiae,Baker's Yeasts,Yeast, Baker
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations

Related Publications

C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo
March 1999, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo
April 1978, The Journal of antibiotics,
C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo
February 1986, The Journal of antibiotics,
C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo
July 1975, The Journal of antibiotics,
C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo
June 1980, The Journal of antibiotics,
C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo
January 1976, Journal of the Chemical Society. Perkin transactions 1,
C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo
July 1973, The Journal of antibiotics,
C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo
March 1984, Nihon rinsho. Japanese journal of clinical medicine,
C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo
December 1995, Pharmaceutical research,
C Battistini, and G Franceschi, and F Zarini, and G Cassinelli, and F Arcamone, and A Sanfilippo
March 1983, Revista medica de Chile,
Copied contents to your clipboard!